We are Stibbe Intellectual Property specialists

Our relationships with clients are built on a foundation of trust, assisting them with the sensitive nature of identifying viable and effective IP strategies.

Intellectual Property

Our IP practice group puts proven expertise at our clients’ disposal for the enforcement and exploitation of their intellectual property. For years, our team has provided effective representation in IP protection and in potential or actual disputes, contracting, transactions and litigation.

On the menu to the right you will find a list of IP specialisms we provide leading companies, multinationals, government agencies and non-government organisations. The sectors are just as diverse comprising finance, life sciences, biotech, chemistry, technology, consumer goods, food, retail, luxury products, publishers and the entertainment industry.

Our IP specialists have decades of domestic and cross-border experience in IP law and have a deep understanding of the business implications of related issues in particular, the transfer of knowledge, trade secrets and protection of know-how. They also work closely in transactions with other practice groups such as TMT, tax, EU competition, employment, criminal law, capital markets, and our M&A practice.

From an international perspective, we have special expertise in multi-jurisdictional procedures where important IP rights form the subject matter of a dispute in parallel proceedings in various countries. In such cases we draw on long-standing relationships with top tier IP firms around the world.

Subscribe to newsletter

Experience

Market recognition

We are very happy with our relationship with the team. In particular, we appreciate its general responsiveness, along with the concise and clear answers it provides. Prosecution and litigation are particular strengths of the firm.

Chambers Europe 2014, Intellectual Property chapter

Stibbe provides ‘a very good service level’ in all areas of IP law

Legal 500 2015, Intellectual Property chapter

Other specialists

Related news

04.07.2016 BE law
The impact of Brexit on the pharmaceutical industry

Trends - Following the Brexit referendum, the UK should, in principle, notify its decision in the coming months to withdraw from the EU as provided by Article 50 of the Treaty on the European Union. According to Article 50, the Treaties will cease to apply to the UK from the date of entry into force of the withdrawal agreement or, failing that, two years after the notification—unless the European Council, in agreement with the UK, decides to extend this period unanimously.

Read more

27.06.2016 BE law
The International Comparative Legal Guide to: Pharmaceutical Advertising 2016 – Belgium Chapter

Articles - ICLG’s International Comparative Legal Guide to: Pharmaceutical Advertising 2016 provides corporate counsel and international practitioners with a comprehensive worldwide legal analysis of pharmaceutical advertising laws and regulations, including advertisements to healthcare professionals, gifts and financial incentives, and so on.

Read more

Our website uses cookies: third party analytics cookies to best adapt our website to your needs & cookies to enable social media functionalities. For more information on the use of cookies, please check our Privacy and Cookie Policy. Please note that you can change your cookie opt-ins at any time via your browser settings.

Privacy and Cookie Policy